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Abstract
Acute myeloid leukemia (AML) is a genetically heterogeneous clonal disorder characterized by two molecularly dis-
tinct self-renewing leukemic stem cell (LSC) populations most closely related to normal progenitors and organized
as a hierarchy. A requirement for WNT/β-catenin signaling in the pathogenesis of AML has recently been suggested
by a mouse model. However, its relationship to a specific molecular function promoting retention of self-renewing
leukemia-initiating cells (LICs) in human remains elusive. To identify transcriptional programs involved in the main-
tenance of a self-renewing state in LICs, we performed the expression profiling in normal (n= 10) and leukemic (n =
33) human long-term reconstituting AC133+ cells, which represent an expanded cell population in most AML
patients. This study reveals the ligand-dependentWNTpathway activation inAC133bright AMLcells and shows a diffuse
Abbreviations: AML, acute myeloid leukemia; LSC, leukemic stem cell; LT-HSCs, long-term hematopoietic stem cells; CFU, colony forming units; CFU-GM, granulocyte/
macrophage; BM MNCs, bone marrow mononuclear cells; LIC, leukemia-initiating cell
Address all correspondence to: Alessandro Beghini, PhD, Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, via Viotti 3/5, 20133
Milano, Italy. E-mail: alessandro.beghini@unimi.it
1This work was supported in part by PUR 2008 (to A.B.), Progetto Integrato Oncologia 2006 (RO 4/2007), Associazione Malattie del Sangue Onlus (AMS), and Piano
Regionale Sangue-Regione Lombardia 2006 (DDG 7917). The authors declare that they have no competing financial interests.
2This article refers to supplementary materials, which are designated by Table W1 and W2 and Figure W1 and are available online at www.neoplasia.com.
3F. Corlazzoli and L. Del Giacco contributed equally to this work.
Received 7 September 2012; Revised 15 October 2012; Accepted 18 October 2012
Copyright © 2012 Neoplasia Press, Inc. All rights reserved 1522-8002/12/$25.00
DOI 10.1593/neo.121480
www.neoplasia.com
Volume 14 Number 12 December 2012 pp. 1236–1248 1236
expression and release ofWNT10B, a hematopoietic stemcell regenerative-associatedmolecule. Theestablishmentof
a primary AC133+ AML cell culture (A46) demonstrated that leukemia cells synthesize and secrete WNT ligands, in-
creasing the levels of dephosphorylated β-catenin in vivo. We tested the LSC functional activity in AC133+ cells and
found significant levels of engraftment upon transplantation of A46 cells into irradiated Rag2−/−γc−/− mice. Owing
to the link between hematopoietic regeneration and developmental signaling, we transplanted A46 cells into develop-
ing zebrafish. This system revealed the formation of ectopic structures by activating dorsal organizer markers that act
downstream of the WNT pathway. In conclusion, our findings suggest that AC133bright LSCs are promoted by mis-
appropriating homeostatic WNT programs that control hematopoietic regeneration.
Neoplasia (2012) 14, 1236–1248
Introduction
Different genetic causes result in variable clinical courses of acute
myeloid leukemia (AML) and different responses to standard chemo-
therapy including stem cell transplant. Despite the genetic differences
among individual patients, most AML clones display certain common
features. Ample evidence exists in mouse models that AML develops
through the stepwise acquisition of collaborating genetic and epigenetic
changes in self-renewing LICs, which exhibit a committed myeloid
immunophenotype and give rise to nonleukemogenic progeny in a
myeloid-restricted hierarchy [1–3]. An important issue to understand
the early events in the origin of AML is the observation that long-term
hematopoietic stem cell (LT-HSC) expansion precedes the generation
of committed myeloid LICs [4].
Although well-orchestrated cell intrinsic programs and environmental
cues represent the main contributory factors for normal LT-HSC ex-
pansion, it is still unclear if transcriptional programs responsible for the
expansion of premalignant LT-HSC populations and leukemia initiation
share common embryonic or post-embryonic functions, such as stem
cell renewal, tissue repair, and regeneration [5,6]. Even though recent
studies have addressed the role of Hedgehog signaling for maintenance
of cancer stem cells in myeloid leukemia [7], its requirement in AML
remains controversial [8].
Recently, the notion that LICs are restricted only to the CD34+CD38−
population has been challenged [9,10] and it has been suggested that
more cell surface markers could be appropriately used to enrich the
leukemia-initiating cell (LIC)–containing fraction. One of such markers
is the AC133 antigen (a glycosylation-dependent epitope of CD133)
that defines a desirable population of stem and progenitor cells con-
taining in turn all the CD34brightCD38− progenitors, as well as the
CD34brightCD38+ cells committed to the granulocytic/monocytic line-
age [11]. In addition, AC133 represents a well-documented marker of
tumor-initiating cells in a number of human cancers [12]. In this study,
fluorescence-activated cell sorter (FACS) analysis demonstrates that
AC133+ cell population is dramatically expanded in 25 AML cases ana-
lyzed. We carried out genome-wide transcriptional analysis of AC133+
cells isolated from newly diagnosed non-promyelocytic AML patients
(n = 33) and healthy donors (n = 10). Results obtained from a multistep
analysis of the generated data defined the involvement of the ligand-
dependentWNT receptor signaling pathway as the self-renewal associated
signature in the AC133-enriched fraction in human AML. Furthermore,
the results presented here suggested thatWNT10B and otherWNTgenes
expressed during the regenerative process of the hematopoietic system
[13,14] are aberrantly upregulated in AC133bright AML cells. To obtain
a localized detection of each single transcript, we first applied an in situ
detection of individual mRNA molecules [15] on bone marrow (BM)
sections from AML patients. By the establishment of a primary culture
of AC133+ AML cells (termed A46 hereafter), we confirmed that secreted
WNTs activated a β-catenin/human T-cell factor (TCF) transcription–
based reporter construct. Moreover, we intend to clarify the relationship
between the abnormal WNT activation in AC133+ population and the
leukemic stem cell (LSC) activity.UsingRag2−/−γc−/− as immunodeficient
xenotransplantmodel [16], AC133+ A46 cells were injected intravenously
into sublethally irradiated mice.
To achieve a complete view of how AC133+ A46 cells modulated
the microenvironment and given that hematopoietic regeneration
converge to developmental signaling, we used zebrafish embryonic
model as an in vivo biosensor.
Our results confirmed previously reported data [17] and raise new
important implications for the involvement of the ligand-dependent
canonical WNT pathway in AML. These suggestive findings are sup-
ported by the pivotal function of WNT in promoting self-renewal
[18,19], its emerging role in myeloid leukemogenesis [20,21], and
the effects of its constitutive activation through a stabilized form of
β-catenin, by inducing quiescent stem cells to enter the cell cycle and
arresting their differentiation [22,23].
Materials and Methods
Collection of Patient Samples and Normal Hematopoietic Cells
BM MNCs were collected from 33 newly diagnosed, unselected
non-promyelocytic AML patients, according to Niguarda Hospital’s
Ethical Board–approved protocols (116_04/2010). According to the
revised Medical Research Council risk group stratification, based on
cytogenetic and molecular markers/mutations [24], samples included
14 adverse, 13 intermediate, and 6 favorable risk patients. Human
adult BM cells obtained from 10 consenting healthy donors were
processed as previously described [25].
Cell Sorting and Flow Cytometry
We carried out AC133+ cell separation based onMACSMicroBeads
and cytofluorometric determinations, as previously described [25].
Microarray Expression Analysis
Total RNA for expression profiling was extracted using RNAqueous-
4PCR kit (Ambion, Austin, TX) from AC133-selected cells. Expression
profiling was performed on Affymetrix HGU133plus2.0 GeneChip
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arrays according to the manufacturer’s procedures. The bioinformatics
analysis performed in this study was realized using the R language for sta-
tistical computing (http://www.r-project.org/) and the annotation librar-
ies provided by the Bioconductor project (http://www.bioconductor.
org/). Microarray data have been deposited in ArrayExpress (http://
www.ebi.ac.uk/arrayexpress/), with accession number E-MTAB-220.
We performed a genome-wide analysis to select genes differentially ex-
pressed between AML AC133+ patients and AC133+ healthy donors
(Welch t test, 0.05 significance level). The resulting set of differentially
expressed genes has been analyzed for functional enrichment with re-
spect to the terms of the Biological Process (BP) branch of the Gene
Ontology (GO) and the pathways of the KEGG database. We relied
on three different methods for functional enrichment analysis: GOStats
(version 2.12.0 of the Bioconductor package, http://www.bioconductor.
org/packages/release/bioc/html/GOstats.html) [26], Database for Anno-
tation, Visualization and Integrated Discovery (DAVID; http://david.
abcc.ncifcrf.gov/home.jsp) [27], and the iterative procedure of dysregu-
lated pathway analysis proposed by Majeti et al. [17]. The first two tests
are based on the hypergeometric distribution, whereas the last one is
based on a non-parametric test and on an iterative procedure. Over-
represented GO terms and KEGG pathways have been selected at
0.05 significance level.
WNT/β-catenin Responsive Luciferase Assay
HEK293T cells grown in 24-well plates at a density of 1.7 × 105 cells
per well were transfected with M50 Super 8x TOPFlash (plasmid
12456; Addgene, Cambridge, MA) and pRL-TK (Renilla luciferase;
Promega, Madison, WI) using jetPEI (Polyplus, New York, NY). Cells
were treated for 12 hours with A46 conditioned medium (CM) or
HEK293T cells transfectedwithBA-WNT10B (plasmid 1831;Addgene)
CM as positive control. WNT10B expression in HEK293T transfected
with BA-WNT10B was evaluated by SYBR Green–based real-time re-
verse transcription–polymerase chain reaction (RT-PCR) using
WNT10B FW-5′-GCTGTAACCATGACATGGAC-3′ and RW-5′-
CTGCCTGATGTGCCATGAC-3′ specific primers. Luciferase activity
measurement was performed with the Dual-Luciferase Reporter Assay
System (Promega).
Immunoblot
Protein expression was assessed by immunoblot analysis using stan-
dard procedures, applying anti–active β-catenin (ABC) monoclonal
mouse (anti-ABC clone 8E7; Millipore, Billerica, MA), anti–β-catenin
monoclonal rabbit (E247; Abcam, Cambridge, United Kingdom), an-
ti–WNT10B polyclonal rabbit (H-70; Santa Cruz Biotechnology, Inc,
Santa Cruz, CA), anti–WNT10B monoclonal mouse (5A7; Abcam),
anti–glyceraldehyde-3-phosphate dehydrogenase (GAPDH) polyclonal
rabbit (ab97626; Abcam), and anti–Pygopus 2 polyclonal rabbit (H-216;
Santa Cruz Biotechnology, Inc) antibodies. Secondary antibodies
used were anti–mouse HRP, anti–goat HRP, and anti–rabbit HRP
(Thermo Fisher Scientific, Waltham, MA).
In Situ mRNA Detection
In situ detection of individual mRNA molecules was performed as
described [15]. One micromolar of locked nucleic acid–modified cDNA
primer (WNT10B, 5′-C+A+G+G+C+CGGACAGCGTCAAGC-
ACACG-3′; β-actin, 5′-C+TG+AC+CC+AT+GCCCACCATCA-
CGCCC-3′; Exiqon, Vedbaek, Denmark) was added to the reverse
transcriptase reaction. Ligation was then carried out with 0.1 μM of
the WNT10B padlock probe or β-actin padlock probe (WNT10B,
5′-[Phos]ACCGTGCCTGTCGGACCCTCCTCTATGATTA-
CTGACCTAAGTCGGAAGTACTACTCTCTTCTTC-
TTTTAGTGAAGCCCAGGCAACCCA-3′; β-actin, 5′-[Phos]
GCCGGCTTCGCGGGCGACGATTCCTCTATGATTACTGA-
CCTATGCGTCTATTTAGTGGAGCCTCTTCTTTA-
CGGCGCCGGCATGTGCAAG-3′; Sigma-Aldrich, St Louis, MO).
Rolling circle products (RCPs) were visualized using 100 nM of detec-
tion probe (WNT10B, 5′-Cy5-AGTCGGAAGTACTACTCTCT-3′
and β-actin, 5′-Cy3-TGCGTCTATTTAGTGGAGCC-3′; Sigma-
Aldrich). Nuclei were counterstained with 100 ng/ml Hoechst 33258
(Sigma-Aldrich). Images of BM tissue slides were acquired using an
Axioplan II epifluorescence microscope (Zeiss, Munchen, Germany)
equipped with a charge-coupled device (CCD) camera (HRM, Zeiss)
and a computer-controlled filter wheel with excitation and emission filters
for visualization of 4′-6-diamidino-2-phenylindole (DAPI), Cy3, and Cy5.
A ×20 objective (Plan-Apocromat, Zeiss) was used for capturing the images.
Images were collected using the Axiovision software (release 4.3, Zeiss).
Images were collected as z-stacks to ensure that all RCPs were imaged, with
a maximum intensity project created in Axiovision. For quantification, the
numbers of RCPs and cell nuclei in images were counted digitally using
CellProfiler software (www.cellprofiler.org) on three ×20 microscope
images. The total number of RCPs was divided by the number of nuclei
for each image. The average for each sample was then calculated from the
result of the three images and is reported as RCPs per cell.
Immunostaining
Direct and indirect immunostaining were performed following stan-
dard procedures. BM biopsies of AML patients, previously embedded in
paraffin blocks, were cut in 5-μm-thick sections and mounted on slides.
Slides were incubated with primary antibody mouse anti-CD133.1
(AC133) (1:100;Miltenyi Biotec GmBH, BergischGladbach, Germany),
directly labeled with 488-nm dye (Sigma), and with primary antibodies
such as mouse anti-ABC (1:100; Millipore), rabbit anti-WNT10B
(H70) (1:100; Santa Cruz Biotechnology, Inc), rabbit anti–Pygopus
2 (H-216) (1:100; Santa Cruz Biotechnology, Inc), goat anti-SMYD3
(F-19) (1:100; Santa Cruz Biotechnology, Inc). Samples were incubated
with the secondary antibodies donkey anti-mouse Alexa Fluor 488
(1:500; Life Technologies, Carlsband, CA), donkey anti-rabbit Alexa
Fluor 568 (1:500; Life Technologies), and donkey anti-goat Alexa Fluor
568 (1:500; Life technologies). Nuclei were counterstained with 100 ng/ml
DAPI (Sigma-Aldrich). Cells were analyzed using the upright micro-
scope (Leica, DM 4000B).
Immunofluorescence Image Analysis
Image analysis was performed bymeans of a custom automatic routine
and the ImageJ program (1.43s; National Institutes of Health, Bethesda,
MD). Maps of ABC+/WNT10B+ cells were obtained using an auto-
matic threshold based on moments algorithm newly implemented in
the ImageJ program and mathematical morphology plugin developed
by D. Prodanov (http://rsbweb.nih.gov/ij/plugins/gray-morphology.
html). DAPI staining was used to identify nuclei. Finally, images of
nuclei for positive cells were obtained by Boolean AND operations be-
tween DAPI staining and cell maps. The resulting images were used to
determine the percentage of ABC+/WNT10B+ cells both manually or
through the Analyze Particles function of ImageJ.
Cell Culture
Selected AC133+ cells from BM at AML diagnosis were cultured
for 16 weeks. The culture was performed using synthetic medium
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StemSpam H3000 (StemCell Technologies, Vancouver, Canada) in
the absence of serum and cytokines. StemSpan H3000 and HPGM
media, conditioned by the cell culture, were collected after 12 weeks,
refined with 0.2-μm filter and stored at −20°C. HEK293T cells
were grown in Dulbecco’s modified Eagle’s medium (high glucose
with sodium pyruvate and L-glutamine; Euroclone), supplemented
with 10% FBS (Euroclone) and penicillin-streptomycin solution
(100×) (Euroclone, Milano, Italy).
Mice and Xenogeneic Transplantation
Rag2−/−γc−/− BALB/c mice were bred and maintained under specific
pathogen-free conditions in the mouse facility of Istituto Oncologico
Veneto, and experiments were performed according to state guidelines
and approved by the local ethics committee. Rag2−/−γc−/− mice at
6 weeks were sublethally irradiated with 5 Gy and transplanted via the
tail vein with 1 × 106 of human AC133+ AML cells (A46).
Evaluation of Hematopoietic Chimerism by Flow Cytometry
Three weeks after transplantation, recipient mice were sacrificed and
BM cells were harvested by flushing femurs and tibias. BM engraftment
was evaluated using human antibodies CD34, CD38, AC133, and
CD45 [BD Biosciences (Bedford, MA) and Miltenyi Biotec GmBH].
Multicolor flow cytometric analyses were performed using FACSCalibur
flow cytometer (BD Biosciences) and analyzed by FlowJo software (Tree
Star, Ashland, OR). Cell engraftment was determined by expression of
the human panleukocyte marker CD45.
Zebrafish Models and Transplantation Procedures
Embryos were handled according to relevant guidelines. Fish of the
AB strain were maintained at 28°C on a 14-hour light/10-hour dark
cycle and collected by natural spawning. Transplantation of human
A46 cells into zebrafish embryos was performed as previously reported
[28]. Briefly, fluorescently labeled A46 cells were resuspended in 1×
phosphate-buffered saline and injected into zebrafish blastulae (be-
tween 100 and 200 cells per injection) at 3 hours post-fertilization
(hpf ). Injected live embryos were observed under a fluorescent micro-
scope at 30% of epiboly to ensure the presence of labeled A46 cells.
Embryos were collected at the desired developmental stages, immediately
fixed, and processed for whole-mount in situ hybridization according
to Thisse et al. [29], using gsc, ntl, and pax2a DIG-labeled riboprobes.
Results
AC133+ Cells Are Highly Expanded in AML
AC133 antigen is restricted to a rare cell population with long-term
reconstituting activity, ranging from 20% to 60% of all CD34+ cells,
and resulting barely detectable in CD34−Lin− cells [11–30]. We have
previously shown that AC133+ LT-HSCs are also highly enriched in
colony forming units and have a stronger granulocyte/macrophage
differentiation potential relative to unselected BM MNCs. However,
their burst-forming units–erythroid forming potential is lower [25]. To
determine the range of expansion of AC133+ cell fraction in AML, flow
cytometric quantification of CD133.1 (AC133) expression either in
single staining or in combination with the pan-hematopoietic marker
CD45 was performed in BM on 25 primary non-promyelocytic AML
samples and 10 age-matched healthy volunteer adult donors. The re-
sulting CD133.1+ cell fraction results expanded among AML patients
by a median of 31.5% [interquartile range (IQR), 16.5%–53.4%] with
respect to normal donors (median, 0.54%; IQR, 0.17%–1.14%; P <
.0001; Figure 1, A–C). To directly compare the gene expression profiles
of purified populations highly enriched in LSCs or HSCs, positive selec-
tion of CD133.1+ cells was performed on all the 33 non-promyelocytic
AML patients (25 de novo, 7 secondary to myelodysplasia, and 1 second-
ary therapy-related; Table W1) as well as on the 10 healthy donors
recruited to this study, respectively. MNC selection in samples from
AML patients led to an average of 236-fold enrichment of AC133-
positive cells (IQR, 142.72–419.44, data not shown).
Identification of Dysregulated Pathways in AC133+ AML
Cell Fraction
To identify the dysregulated pathways in AC133+ AML cell frac-
tion versus normal long-term reconstituting AC133+ HSC cells, we
performed a genome-wide functional enrichment analysis on gene ex-
pression microarray data of 33 AML patients and 10 healthy donors.
The identification of overrepresented pathways in AC133+ AML cells
was realized through three computational tools: GOStats [26], DAVID
[27], and dysregulated pathway analysis according to Majeti et al. [17].
Employing the functional terms from GO BPs and the pathway infor-
mation from KEGG databases, we found 212 functionally enriched
GOBP terms with GOStats (P < .01), 284 GOBP terms with DAVID
(P < .05), and 616 GO BP terms with the non-parametric test of
Majeti et al. (P < .05). Moreover, GOStats selected 16 KEGG pathways
Figure 1. Human AC133+ cells are strongly expanded in AML. Representative dot plots of the immunophenotype analysis from the BM of
(A) a healthy donor and (B) a patient with AML (AML No. 42 in Table W1). The CD45/CD133.1 co-staining was gated on BMMNCs; percent-
ages on total cellularity are shown for gated normal and AML populations. (C) Flow cytometry analysis of the CD133.1 antigen in BMMNCs
of healthy donors (n=10) and AML patients (n=25). The IQR for each sample group is indicated in the dot. Mann-WhitneyU test was used
to calculate the P value (α = 0.001).
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Figure 2. Schematic visualization of dysregulated networks in KEGG database and representation of WNT gene expression profiles.
(A) Visualization of WNT signaling pathway in the KEGG database. Highlighted genes are differentially expressed and red-starred path-
ways are overrepresented in AC133+ AML cells. (B) Heat map of the differentially expressed WNT-associated genes. The color bar under
the patient sample dendrogram identifies AML samples (red) and healthy controls (blue). The names, accession numbers, as well as
P values for the differentially overexpressed and underexpressed genes are shown in the right panels.
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(P < .05), DAVID selected 24 KEGG pathways (P < .05), and the
dysregulated pathway analysis selected 3 KEGG pathways (P < .05).
As shown in Table W2, DAVID ranks the WNT signaling pathway
(P = .022) among the first 10 dysregulated pathways in AC133+
AML cells. The visualization of the WNT molecular interaction in
KEGG database is presented in Figure 2A.
It is worth noting that different statistical methods agree in identify-
ing theWNT pathway as a significant dysregulated pathway in AC133+
AML cells. Moreover, the WNT signaling pathway in KEGG is se-
lected as overrepresented in AC133+ AML stem cells by both GOStats
and DAVID. Taken together, the functional enrichment methods
select the term “WNT receptor signaling pathway” (GO:0016055)
as the most specific self-renewal associated dysregulated pathway.
WNT Gene Expression Profiles of Normal and Leukemia
Long-term Reconstituting AC133+ Cells
To obtain insights into theWNTpathway in AC133+ leukemia cells,
we focused our analysis on the probe sets annotated to “WNT receptor
signaling pathway” GO class or to any of its children GO terms. The
resulting probe set list was complemented with the probes mapping to
genes in a manually curated list of WNT target genes and with probes
mapping to other well-known WNT genes, not included in the previ-
ous two lists. The total list of analyzed WNT genes includes 480 probe
sets, mapping to 193 different genes (Table_A in http://homes.dsi.
unimi.it/~re/TRdataset/). To assess differential expression of WNT
genes, we employed Welch t tests (two-tailed) on the 480 probe sets,
thus identifying 103 differentially expressed genes (P < .05; Figure 2B).
Genes shown to be highly AML-specific include the WNT ligands
WNT2B, WNT6, WNT10A, and WNT10B [14], the WNT/β-catenin
signaling agonists including SMYD3 [31], DKK2 [32], SOX4 [33],
PROP-1 [34], and PYGO2 [35,36], antagonists including WIF-1
[37], KLHL12 [38], LRP6 [39], KREMEN1 [40], E2F1 [41], DACT1
[42], and HBP1 [43], and the deregulated WNT targets including
STAT3, MYCN, ABCC4, DLX3, MARK4, RUNX2, CD24, and
CD44 [44]. Collectively, these data are consistent with ligand-dependent
activation of the regeneration-associated WNT pathway [14].
We also investigated whether the expression of the WNT genes
varied between the risk groups in AML (favorable, intermediate, and
adverse) revised by Smith et al. [24]. Clustering results of AML cases
restricted to WNT genes show that the risk groups are not clearly
distinguishable in separate clusters (Figure 2B). Analysis of variance
between groups confirms these results: only 3 (ABCC4, HBP1, and
NDP) of 193 WNT-related genes are differentially expressed across
the three categories (P < .05). Thus, our data do not support a signif-
icant distinction between risk groups in AML patients. This state-
ment should be considered with caution, because the cardinality
of the subgroups is relatively low (6 favorable, 13 intermediate, and
14 adverse samples).
Hyperactive WNT Signaling Resulted Activated in
Diffuse AC133bright AML Cells Expressing the
Hematopoietic Regenerative Molecule WNT10B
Most of what is known about hematopoietic regeneration point to
WNT signaling pathway and specifically toWNT10B [13,45]; therefore,
Figure 3. Altered WNT signaling in AC133+ AML cells. (A) Detection with padlock probe and target-primed rolling circle amplification of
individual WNT10B transcripts on BM slides from AML patients. Green RCPs represent WNT10B transcripts, and red RCPs represent
β-actin transcripts in consecutive sections. Cell nuclei are shown in blue. Images were acquired with ×20 magnification. Scale bar, 10 μm.
(B) The quantification of RCPs was done on three ×20 images of BM biopsies of AML patients. For quantification, the numbers of RCPs
of each image were counted digitally using CellProfiler software. The average of RCPs for each sample was calculated and it is reported as
a ratio between β-actin and WNT RCPs. (C) Immunoblot analysis of ABC, β-catenin (as detected with the N-terminal pan–β-catenin antibody),
WNT10B, and Pygopus 2 protein expression in AC133+ cell fractions from 18 patient samples and 1 healthy donor introduced as control.
GAPDH, loading control. HD, healthy donor; *therapy-related secondary AML.
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we investigated how expression of WNT10B is related to AML
phenotype. To fully understand mRNA distribution of WNT10B
within BM sections, we focused on the application of single molecule
detection methods. In situ mRNA detection by target-primed rolling
circle amplification analysis offers high sensitivity and localized detec-
tion within single cells and tissues [15]. Following this approach, we
detected WNT10B-related transcript in BM sections obtained at diag-
nosis from two randomly selected patients. β-Actin was included as a
reference transcript in consecutive sections. Visualization by using high-
performance fluorescence microscopy showed a diffuse localization
pattern in the tissues (Figure 3A). Signal distribution and RCP quantifi-
cation showed a β-actin/WNT10B ratio close to 1, suggesting a con-
stitutive activation of WNT10B transcription in the BM (Figure 3B).
In addition, we analyzed transcriptional activation of canonical WNTs
focusing on genes that have been shown to be potent regulators of stem
cell functions. N-terminally dephosphorylated β-catenin (ABC) was
increasingly accumulated as determined by immunoblot analysis (Fig-
ure 3C). Remarkably, we confirmed a dramatic increase in WNT10B
expression in all patient samples, except for one, reanalyzed by immuno-
blot (Figure 3C). Interestingly, the only AML patient negative for the
WNT10B expression (AML No. 40 in Table W1) was affected by
therapy-related AML. According to the biologic relevance of PYGO2
in promoting the responsiveness ofWNT signaling [35,36], diffuse over-
expression was detected by immunoblot (Figure 3C). To better elucidate
the impact of the broad WNT10B overexpression on the leukemic
microenvironment, we examined its expression in histologic preparations
of BM from five randomly selected AML patients at diagnosis. Double
immunostaining for WNT10B and ABC, followed by ImageJ analysis,
confirmed that WNT10B was expressed by a high proportion of leuke-
mic cells.We next examined by immunostaining a number of BMbiopsy
sections from five randomly selected cases. In all the analyzed samples,
the AC133 immunostaining revealed islands of highly positive cells
(AC133bright) in an estimated proportion of 8% of cells, amid AC133dim
or negative tumor blasts (Figure 4A). AC133bright cells correlated with
accumulation of ABC (Figure 4, B and C). WNT10B antibody staining
was also detectable in interstitial spaces, suggesting its secretion and re-
lease in the BMmicroenvironment (Figure 4D, top). The slides revealed
thatWNT10B is diffusely expressed (Figure 4,A andD) but that only the
AC133bright small cells (8–10 μm diameter of the nuclei), with a clonal
appearance and increased N/C ratio, shared the WNT signaling activa-
tion signature represented by accumulation of ABC [46], likely induced
through an autocrine/paracrine mechanism (Figure 4, B and D, top).
AC133+ Leukemic Cells Express and Secrete WNT10B
in a Primary Cell Culture
The notion that primary cell cultures closely mimic the in vivo state
and generate more physiologically relevant data led us to establish a
primary AC133+ cell culture (A46). A46 cells, with diploid karyotype,
were selected from a 66-year-old male at diagnosis of AML-M2 (AML
No. 46 in Table W1). Immunophenotype of MNCs before selection
revealed a dominant CD133.1+CD34+CD38−CD45+CD117+ blast
population (59%; Figure 5A), representing an optimal source to establish
an LIC-enriched primary culture. Recently published data implicate the
existence of an immunophenotypic hierarchy in AML, with a minority
of CD38−CD45+ cells giving rise to CD38+CD45+ “GMP-like” cells
at the apex of an LIC hierarchy [10]. The latter finding seems to suggest
that CD38−CD45+ cells start to gain CD38 expression after AC133 se-
lection procedures as observed in sorted cells (Figure 5A). Comparative
analysis of spotted AC133-selected A46 leukemic and normal cells by
Figure 4. β-Catenin activation in the subpopulation of AC133bright
AML cells expressing WNT10B. (A) Representative immunostaining
micrographs show green fluorescence of cells expressing AC133 in
a BM section of AML No. 9 (TableW1). Cell nuclei are shown in blue.
Scale bar represents 10 μm. (B) Co-staining of BM from AML No. 9
adjacent serial section for expression of ABC (green) and WNT10B
(red). Cell nuclei are shown in blue (DAPI). (C) False color maps of
ABC/WNT10B double positive cells (blue) were obtained using an
automatic threshold based on the moments algorithm implemented
in the ImageJ program. DAPI staining was used to identify nuclei.
Images obtained crossing ABC masks with WNT10B signals were
used to count the percentage of ABC/WNT10B double positive cells
over the total number of cells. The macro was validated against
a trained experimenter over a sample of 830 total cells from eight
different images. Differences in results were restricted to less than
0.01%. (D) Morphologic detail of cells showing intense specific
staining for ABC (top panels) and WNT10B (bottom panels). All
images were acquired with a ×40 objective. Scale bars represent
10 μm. Representative images of at least three serial slides from
five randomly selected patients.
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Figure 5. AC133+ A46 cells express and release WNT10B. Dot plots of the immunophenotype analysis from AML No. 46 BM MNCs at
diagnosis and after selection. (A) Patterns of CD38/CD133.1 (top left), CD117/CD45 (top right), and CD34/CD38 (bottom left) co-stainingwere
gated on BM AML cells before selection. Representative CD34 and CD38 expression on Ficoll-selected MNCs (bottom center) and AC133-
sorted cells before culture (bottom right) is shown. Percentages on total cellularity are shown for gated AML populations. (B) Immuno-
staining assessment for WNT10B in AC133+ populations from A46 (top panels) or healthy donor (bottom panels). Representative images
of at least five serial slides. Blue, nuclei; red, WNT10B; merge, WNT10B/DAPI. All images were acquired with a ×40 objective. Scale bars
represent 10 μm. (C and D) TOPFlash reporter assay showing luciferase expression driven by eight TCF/lymphoid-enhancing factor (LEF)
binding sites. (C) Positive control was obtained by CM of pBA-WNT10B–transfected H293T cells. Expression of WNT10B was evaluated
in pBA-WNT10B–transfected H293T by real-time PCR (left). TOPFlash reporter assay shows luciferase expression induced in Super
8x TOPFlash–H293T cells by pBA–WNT10B H293T CM (right). (D) TOPFlash reporter assay showing dose-dependent luciferase expression
induced in Super 8x TOPFlash–H293T cells by A46 CM. Significance was evaluated by the unpaired Student’s t test: *P < .05; **P < .001.
Data represent the mean ± SD of triplicate reactions and are representative of three independent experiments.
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immunostaining revealed WNT10B expression in all A46 AC133+ cells
(Figure 5B, top), whereas normal BM-derived AC133+ cells resulted
negative (Figure 5B, bottom). To further investigate whether the endoge-
nous WNT production had any paracrine effect, we used A46 CM
to evaluate β-catenin–mediated transcriptional activation. To this
aim, HEK293T cells (H293T), transfected with Super 8x TOPFlash
β-catenin/TCF transcription–based reporter construct, were exposed
either to pBA–WNT10B H293T CM as control (Figure 5C) or A46
CM. This construct could be efficiently expressed in a dose-dependent
manner when transiently exposed to A46 CM for 12 hours (Figure 5D).
AC133 Is Expressed on Functional A46 AML LSC
To complement the in vitro observations, we tested whether AC133
was expressed on functional A46 AML LSC. We transplanted A46
cells into sublethally irradiated (5 Gy) 6-week-old Rag2−/−γc−/− mice via
the tail vein. This highly immunodeficient mouse strain lacks mature B,
T, and natural killer (NK) cells, supporting efficient engraftment of
human AML [16]. Transplanted mice were killed at 3 to 8 weeks after
transplantation and analyzed for engraftment of human leukemia cells
in BM (Figure 6A). The results of a typical experiment from three
transplanted mice (M1–M3) are shown in Figure 6, with AC133+
A46 cells showing engraftment of human CD45 (hCD45) cells. We
confirmed that engrafted hCD45+ cells were human myeloid leukemia
blasts by measuring CD34/CD38/CD133 expression (Figure 6B).
Transplantation of A46 Induces Ectopic Axial
Structure Formation in Zebrafish Embryo by WNT
Signaling Activation
To bring our functional analyses full circle, we explored the physio-
logical relevance of tumor-derived WNT signals by using the develop-
ing zebrafish as a biosensor. We hypothesized that WNT-secreting
A46 cells transplanted into developing zebrafish embryos might act as
Figure 6. AC133+ A46 cell transplantation in Rag2−/−γc−/−mice. (A) Overview of the experimental design: 1 × 106 AC133+ A46 cells were
injected into sublethally irradiated Rag2−/−γc−/−mice through the tail vein. Three weeks after transplantation, BM cells were collected and
analyzed by flow cytometry. (B) Expression profiles of three recipient mice (M1–M3) are shown. hCD45+ population was identified in BMs of
mice, and within hCD45+, the expression patterns of hCD34 and hCD133.1 (AC133) were analyzed. Cells were separated in subpopulations
according to the expression of hCD34 and hCD133.1 and then analyzed for hCD38 and hCD133.1 expressions.
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ectopic sources of maternal WNT ligands. Cell-grafted embryos,
injected at or before the mid-blastula transition stage (∼3 hpf) with
Hoechst 33342 fluorescently labeled A46 cells (Figure 7A), showed
the expression of the organizer-specific gene goosecoid (gsc). Expression
of gsc is typically initiated by the nuclear translocation of maternal
β-catenin triggered by the activation of the WNT signaling. While
normal AC133+ cells did not alter the normal expression of the gene
(Figure 7B), approximately 30% of the embryos grafted with A46 cells
(n = 208) displayed both the expansion of the gsc endogenous domain
and the activation of the gene in ectopic positions (Figure 7, C and D).
Consistent with our hypothesis, the A46 cells retain a dorsal organizer–
inducing activity possibly correlated with their strong WNT signaling
activation. In addition, grafted embryos developed secondary axial struc-
tures, ranging from additional tail tissues (Figure 7, E–H) to an almost
fully formed ectopic head (Figure 7I ). Control embryos grafted with
normal BM-derived AC133+ cells, devoid of any WNT signaling ac-
tivity, did not display alterations of the normal phenotype (data not
shown). The identity of the additional tail structures was confirmed
by in situ hybridization staining for the notochord and tail bud marker
ntl [47], whereas the emergence of ectopic head structures was high-
lighted by pax2a labeling optic stalk, midbrain–hindbrain boundary,
and otic vesicles. These results imply that A46 cells might determine
the establishment of an additional source of signal, with a Nieuwkoop
center–like activity, able to induce an extra dorsal organizer, similarly
to the endogenous situation at mid-blastula transition, when maternal
WNT/β-catenin signaling initiates the formation of the dorsal orga-
nizer [48]. In zebrafish, secondary axis can be also induced by Nodal,
a highly evolutionarily conserved morphogen belonging to the trans-
forming growth factor–β superfamily and able to activate gsc expression
[49]. Therefore, we investigated the possible involvement of the Nodal
signaling pathway in the dorsal organizer induction mediated by A46
cells. The complete lack of Nodal expression observed after microarray
analyses was confirmed by qualitative RT-PCR in A46 and samples
from six different AML patients (Figure W1), allowing to exclude any
Nodal contribution from A46 cells to the formation of the secondary
axis and induction of gsc expression.
Discussion
The deceivingly homogeneous, undifferentiated morphology of the
AML blasts is now known to mask a heterogeneous collection of cells
that recapitulate the hierarchy of precursor cells that characterize the
normal process of blood-cell differentiation. The concept that LIC
properties occur in a self-renewing non-HSC progenitor cell popula-
tion, preceded by the expansion of a preleukemic LT-HSC, has been
recently reinforced [4,10]. However, the molecular functions respon-
sible for the preleukemic LT-HSC expansion and the acquisition of
self-renewal ability in AML remained poorly defined.
The WNT/β-catenin pathway has been show to play a critical role
in the regulation of cell proliferation, differentiation, and apoptosis of
different malignant entities. It is highly regulated in AML [50] and
also involved in the self-renewal process of HSCs. WNT/β-catenin
pathway requirement for LIC development in AML has emerged
in mouse model [21]. Recent studies revealed aberrant WNT signal-
ing in AML cells that is independent from the occurrence of AML-
associated fusion proteins or mutations in tyrosine kinase receptors
[reviewed in 20].
The results presented here using gene expression microarrays and
pathway analysis provide direct evidence that the WNT/β-catenin sig-
naling is diffusely activated in the AC133+ AML population, with a spe-
cific transcriptional signature involving overexpression of the WNT
pathway agonists and down-modulation of the major antagonists.
Although the long-term reconstituting human HSC marker AC133
has been detected in a majority of CD34+ AML [51], no extensive data
concerning the role of AC133 in AML were available.
Analysis of freshly fractionated cells from AML patients showed that
active WNT signaling was predominant in the population highly en-
riched for the AC133 marker. Notably, WNT2B, WNT6, WNT10A,
and WNT10B, known to promote hematopoietic tissue regeneration
[13,14], are the WNT mediators specifically upregulated in the AC133+
Figure 7. A46AML cells induce ectopic gene expression and second-
ary body axis formation upon transplantation in zebrafish embryos.
(A) Fluorescence microscopy of a live zebrafish embryo at 30% of
epiboly (lateral view) transplanted at 3 hpf at the animal pole region
with A46 cells previously blue-stained with Hoechst 33342. (B–D)
Dorsal side view of 70% epiboly-stage embryos hybridized with
a gsc-specific probe. Embryos have been injected with (B) normal
AC133+ cells as control or (C and D) A46 AML cells. The arrow-
heads indicate the gsc endogenous signal, while arrows specify
the position of zebrafish cells expressing ectopic gsc. (E) Bright-field
microscopy of a 24-hpf zebrafish embryo injected with A46 AML
cells (lateral view). The arrowhead and the dotted line indicate the
secondary trunk/tail induced by A46 cells. (F, G) The embryo in E
has been hybridized with a probe specific for the notochord and tail
bud marker ntl. (F) The probe labels the notochord (n) in the endoge-
nous trunk and the chordoneural hinge (cnh) in both tails (G, higher
magnification). (H) Tail of a 24-hpf embryo hybridized with ntl-
specific probe. The endogenous (n) and ectopic (*n) ntl signals run
parallel along the axis of the embryo, indicating the presence of
additional axial structures. (I) Dorsal view of a 24-hpf embryo that de-
veloped an ectopic head on the side of the endogenous one, as indi-
cated by the expression of the brain marker gene pax2a. The dotted
lines indicate the main (M) and secondary (S) axes. The optic stalk
(OS) in close vicinity to the eye (e), the midbrain-hindbrain boundary
(MHB), and the otic vesicles (OV) of the embryo are stained with the
pax2a riboprobe, as well as several areas of the ectopic head (the
asterisks indicate the twoclearly recognizable additional otic vesicles).
The image is composed of different pictures corresponding to several
focal planes, since the embryo is not flat, and a single focal plane
cannot comprise all the labeled structures belonging to the main
and secondary axes. Scale bars represent 125 μm (A–D), 150 μm
(E), 40 μm (F), 15 μm (G and I), or 25 μm (H).
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AML cells. In addition, there is evidence that in the hematopoietic
systemWNT10B is specifically and significantly upregulated following
an injury and that WNT10B acts to enhance the growth of HSCs [13].
It is also worth noting that greater fold expansion of murine HSC
progenitors was obtained after WNT10B CM exposure [52]. Consis-
tent with the latter observations, we showed a dramatic increase of
WNT10B expression and protein release within the microenviron-
ment in the large majority of samples from AML patients recruited
to this study, with the exception of the unique therapy-related AML
patient. In accordance with previous reports [52], we have not detected
WNT10B gene expression in normal AC133+ hematopoietic cells.
Moreover, our data also point to the strong expression of the WNT
target gene CD44 and the loss of CD24, according to the expression
of CD44+CD24−AC133+ phenotype that defines a putative cancer
stem cell population also in breast tumors [53]. Interestingly, Dick
et al. have shown that CD44 is a key regulator of AML LSC func-
tion and that targeting it eradicates LSCs [54]. In light of the higher
homeostatic range of WNT/β-catenin signaling occurring upon an acute
injury [55], our study demonstrated the involvement of the regeneration-
associated WNT signaling in AC133bright AML cell fraction. The term
“regeneration” has been used to define the physiological phenomena of
reconstitution from damage due to injury or disease. Hematopoietic
regenerative-associated WNT ligand (WNT10B) is expressed at mRNA
and protein levels on both leukemic blasts and stromal-like cells, indi-
cating a possible autocrine/paracrine involvement of WNT in the BM
microenvironment. Conversely, activation of WNT signaling marked
by expression of the dephosphorylated β-catenin was restricted to the
smaller population of AC133bright leukemic cells. The reasons for these
differences are unclear, but it is possible that β-catenin activation by
WNTs requires the expression of specific Fzd receptors, conferring a
“responsive” phenotype, only restricted to a rare population of cells. In
the HSC biology, a fundamental question is how self-renewal is con-
trolled; several lines of evidence point to Notch for a WNT-mediated
maintenance of undifferentiated HSCs [56]. Recent studies, examining
the molecular targets of WNT10B, have highlighted the nuclear factor
κB and Notch pathways as downstream targets of WNT10B [57]. It is
tempting to speculate that WNT10B and other regeneration-associated
WNTs (i.e., WNT2B, WNT6, and WNT10A) integrate with other
signals, such as Notch, to drive oncogenic renewal. Because activation
of WNT signaling can increase the ability of HSCs to reconstitute the
hematopoietic system of lethally irradiated mice, we transplanted the
AC133+ A46 cells into irradiated Rag2−/−γc−/− mice. Different papers
have been recently published in which comparisons in the engraftment
ability of different immunodeficient murine models were made. The
variability of the reconstitution seemed to be mainly linked to the degree
of immunodepression of the murine host. Rag2−/−γc−/− represents a
powerful model to verify the biologic and malignant characteristics of
human tumor cells. It is characterized by immunodeficiency of T and
B cells caused by Rag2 knockout, coupled with the NK deficit mediated
by the absence of the γc interleukin receptor chain [16]. The results of our
experiments indicate that AC133 is expressed on AML LSC in the A46
primary cells, suggesting that regeneration-associated WNT expression
signature is enriched in primary human AML LSC–containing fraction.
Regeneration requires the rapid expansions of HSCs; this process
is often mediated by reactivation of developmental signal transduction
pathways, such as BMP and WNT [45,58]. In the early embryo, the
WNT factors induce the nuclear translocation of β-catenin, which trig-
gers the formation of the dorsal organizer through the activation of
zygotic dorsal-specific genes [59]. SuchWNT-induced cascade of events
results in the establishment of the embryonic dorsoventral axis [47]. To
test the hypothesis that regeneration-associated WNT signaling is in-
volved in AML LSC expansion, we used a zebrafish embryonic model
as a tool by examining the ability of A46 primary leukemia cells to
modulate embryonic microenvironment. Therefore, we used zebrafish
embryos to show that A46 cells prompt secondary axis development,
inducing the formation of a dorsal organizer–like structure, possibly
through the secretion of different WNT ligands. The mechanisms pro-
moting organizer formation are known to involve cooperation between
Nodal andWNT signaling. However, implanted cell lines with different
origin induce the dorsal organizer independently from the Nodal sig-
naling [60]. Here, we demonstrated that the A46-dependent alteration
of zebrafish development and activation of the organizer-specific gene gsc
are not reliant on Nodal activity.
In summary, the findings we report here implicate, for the first time,
that regeneration-associated ligand-dependent WNT signaling exceeds
the homeostatic range in the majority of human AML cases and affects
responsive AC133bright cells whose renewal is promoted byWNT path-
way activity in vivo. These results not only support that AC133 is ex-
pressed on functional leukemia stem cells, but because developmental
signal transduction pathways are often reactivated during regeneration,
we also show that AC133+ AML cells induce the formation of a dorsal
organizer–like structure in zebrafish embryos.
Finally, these studies suggest that the regenerative WNT signaling
is a stem cell–associated function altered, as a common feature, in
AC133bright AML leukemia stem cell fraction. Future studies will be
required to demonstrate a pathogenic association of AC133bright LSC
regeneration response with AML, in terms of tumorigenicity, clinico-
pathologic features, and patient outcomes.
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Table W1. Clinical Characteristics and Outcome of AML Patients.
No. Age, y/Sex FAB Cytogenetics* FLT3 NPM1 WBC, ×109/L MO Blast, % EML s-AML Response to Induction Relapse Outcome
1 67/M M2 45,XY,−7 wt – 1.7 55 Absent Yes† CR Yes D/first res rel
2 45/M M1 Complex karyotype wt – 1.7 60 Absent No CR No A/first CR
4 59/M M4 46,XY,del(20)(q11;q13) wt – 3.5 32 Absent No CR No A/first CR
5 47/F M4 46,XX ITD – 84.6 80 Skin No CR No A/first CR
6 76/F M4 47,XX,+11 wt – – – Absent Yes† ref dis n.a. D/prim ref dis
9 20/M M0 46,XY wt – 3.6 80 Absent No CR Yes A/second CR
10 62/F M5a 46,XX wt – 69 90 Skin No CR No A/first CR
13 57/M M1 46,XY,t(6;9)(p23;q34) ITD wt 39.7 89 Absent No ref dis n.a. D/prim ref dis
14 72/F M2 46,XX wt – – – Absent No ref dis n.a. D/prim ref dis
16 41/F M2 46,XX wt wt 15.9 45 Absent No CR No A/first CR
17 29/M M1 46,XY ITD wt 217.7 96 Absent No CR Yes D/first res rel
19 29/F M1 46,XX,del(11)(q23) wt – 110.6 95 Skin No ref dis Yes D/first res rel
21 22/M M1 46,XY ITD wt 16.7 75 Absent No CR No A/first CR
23 65/M M1 46,XY wt wt 12.7 78 Absent No CR Yes A/second CR
24 59/M M1 46,XY wt Exon 12 20.1 75 Absent No CR Yes A/first rel
25 39/F M1 46,XX,del(11)(q23) wt wt 15.7 – Absent No ref dis n.a. D/prim ref dis
30 41/M M5a 46,XY wt wt 3.6 75 Absent No CR Yes A/first rel
32 52/F M2 46,XX wt wt 2.7 55 Absent Yes† CR No D/TRM first CR
34 29/M M0 46,XY,del(11)(q13;q23) wt wt 4 86 Absent No CR Yes D/first res rel
38 59/F M1 46,XX wt Exon 12 1 82 Absent No CR Yes D/first res rel
39 51/M n.a. Complex karyotype wt wt 1.2 – Absent No ref dis n.a. D/prim ref dis
40 55/F M2 Complex karyotype wt wt 0.8 20 Absent Yes‡ n.a. n.a. A/active dis
41 62/F M4 46,XX wt wt 17 30 Skin Yes† CR Yes A/first res rel
42 65/F M4 46,XX wt wt 1.2 60 Adnexal mass No ref dis n.a. A/prim ref dis
44 56/F M2 46,XX,t(8;21)(q22;q22) wt wt 8.6 65 Absent No CR Yes A/second rel
46 66/M M2 46,XY ITD wt 26.8 80 Absent No PR n.a. A/prim ref dis
47 62/F M2 47,XX,+21 wt Exon 12 23 12 Absent Yes† n.a. n.a. A/active dis
48 43/M M5a 46,XY ITD Exon 12 63.9 85 Absent No CR Yes A/second CR
49 68/F biphen. 45,XX,−7,t(9;22)(q34;q11) wt wt 8.1 70 Absent No CR Yes A/second CR
50 61/F M4 Complex karyotype wt wt 8.8 35 Absent No ref dis n.a. D/prim ref dis
51 15/F M5b 46,XX wt wt 118 84 CNS No CR Yes D/first res rel
52 33/M M2 46,XY wt Exon 12 20.9 40 Absent No CR No A/first CR
53 51/F M1 46,XX wt Exon 12 81.1 77 Absent No CR No A/first CR
A, alive; CR, complete remission; PR, partial remission; D, dead; ref dis, refractory disease; res rel, resistant relapse; biphen, biphenotypic; TRM, transplant-related mortality; s-AML, secondary AML;
EML, extramedullary leukemia; n.a., not applicable.
*At diagnosis.
†Myelodysplastic AML.
‡Therapy-related AML.
Table W2. Top 10 Dysregulated KEGG Pathways in AC133+ AML Cells.
Term No. of Genes P
Oxidative phosphorylation 78 9.9 × 10−7
Focal adhesion 107 7.0 × 10−3
Neurotrophin signaling pathway 70 7.3 × 10−3
Ribosome 51 1.0 × 10−2
Calcium signaling pathway 94 1.1 × 10−2
Adherens junction 45 1.3 × 10−2
Long-term potentiation 40 1.6 × 10−2
Axon guidance 71 1.9 × 10−2
WNT signaling pathway 80 2.2 × 10−2
Ubiquitin-mediated proteolysis 73 2.3 × 10−3
No. of genes is referred to KEGG pathway.
P is obtained through the modified Fisher exact test (EASE score in DAVID).
Figure W1. Nodal expression analysis on BM samples from AML patients. RT-PCR analysis has been performed to investigate the level of
Nodal expression in AML samples from six different patients (lanes 1 to 6). The analysis has also been performed on BM specimen sampled
from a healthy donor (lane HD), and monitored for quality with a positive control (lane HS401, human embryonic stem cell line HS401) and a
no cDNA negative control (lane neg). A 100-bp molecular weight DNA ladder (Genespin) has been loaded onto the gel for amplicon sizing
(lane L). The analysis pointed out the complete lack ofNodal expression in all the six samples tested, aswell as, unsurprisingly, in the healthy
donor. Arrowhead indicates the size of the Nodal-specific PCR product (392 bp) obtained with the following pair of primers: HuNODAL_ff2:
5′AGGGCGAGTGTCCTAATCCT and HuNODAL_rr: 5′CAGACTCCACTGAGCCCTTC. To further increase the sensitivity of the assay, we have
subjected the PCRs to a second round of amplification using a semi-nested approach with the same reverse primer and with a nested
forward primer (HuNODAL_ff1: 5′GAGGAGTTTCATCCGACCAA). The semi-nested PCR confirmed the total absence of Nodal expression
in all the six samples analyzed, with the expected 366-bp product detected exclusively in the positive control (not shown, figure available
upon request). To further increase the strength of the data, we have performed the same analysis on a second set of seven AML BM speci-
mens, resulting in the exact same outcome (not shown, figure available upon request). GAPDHwas used as internal control to test the good
quality of all the cDNAs used in the experiments (not shown, figure available upon request).
